CATALYST PHARMACEUTICALS INC (NASDAQ:CPRX) – A Strong Contender for Growth Investors

CATALYST PHARMACEUTICALS INC (NASDAQ:CPRX) stands out as a compelling candidate for investors following Louis Navellier’s growth investing principles. The company meets multiple criteria from Navellier’s "Little Book That Makes You Rich," demonstrating strong earnings momentum, expanding profitability, and solid cash flow generation.

Key Strengths of CPRX

• Earnings Revisions & Surprises: Analysts have raised EPS estimates for the next quarter by 5.41% over the past three months. CPRX has also delivered four consecutive positive earnings surprises, averaging a 23.15% beat.
• Revenue & Earnings Growth: Year-over-year revenue growth stands at 29.96%, while quarterly sales surged 43.56%. EPS growth is even more impressive, with a 112.16% increase over the past year and 136.84% quarter-over-quarter.
• Expanding Profitability: Operating margins have grown by 127.31% in the past year, reflecting efficient cost management. The company’s return on equity (ROE) of 24.85% is well above the industry average.
• Strong Cash Flow: Free cash flow growth soared by 123.91% year-over-year, indicating robust financial health.

Valuation & Financial Health

CPRX trades at a P/E ratio of 14.32, below both the industry and S&P 500 averages, suggesting it may be undervalued given its growth trajectory. The company has no debt, a current ratio of 6.14, and a quick ratio of 5.96, underscoring its financial stability.

For a deeper dive into CPRX’s fundamentals, review the full analysis here.

Our Little Book Growth Stock Screener provides more high-growth stock ideas updated daily.

Disclaimer

This is not investment advice. Always conduct your own research before making investment decisions.